The store will not work correctly when cookies are disabled.
4-Bromo-2-fluoro-N-[3-(1H-tetrazol-5-yl)phenyl]benzenesulfonamide
ID: ALA3727849
PubChem CID: 56941606
Max Phase: Preclinical
Molecular Formula: C13H9BrFN5O2S
Molecular Weight: 398.22
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: O=S(=O)(Nc1cccc(-c2nnn[nH]2)c1)c1ccc(Br)cc1F
Standard InChI: InChI=1S/C13H9BrFN5O2S/c14-9-4-5-12(11(15)7-9)23(21,22)18-10-3-1-2-8(6-10)13-16-19-20-17-13/h1-7,18H,(H,16,17,19,20)
Standard InChI Key: QGGLLVQWTIFXTN-UHFFFAOYSA-N
Molfile:
RDKit 2D
23 25 0 0 0 0 0 0 0 0999 V2000
2.3383 -1.3500 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 2.7000 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2990 -0.7500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -1.5000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -3.0008 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
1.0394 -3.6005 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.0006 -4.2008 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.2993 -3.7521 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.2993 -5.2529 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5968 -6.0056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5937 -7.5056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2931 -8.2530 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0044 -7.5003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0013 -6.0003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.3056 -8.2481 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4488 -9.7284 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9172 -10.0350 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6625 -8.7332 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.6547 -7.6221 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
4 6 2 0
6 7 1 0
7 8 2 0
8 2 1 0
8 9 1 0
9 10 2 0
9 11 2 0
9 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 19 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 398.22 | Molecular Weight (Monoisotopic): 396.9644 | AlogP: 2.57 | #Rotatable Bonds: 4 |
Polar Surface Area: 100.63 | Molecular Species: ACID | HBA: 5 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 7 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 4.28 | CX Basic pKa: ┄ | CX LogP: 2.65 | CX LogD: 0.45 |
Aromatic Rings: 3 | Heavy Atoms: 23 | QED Weighted: 0.70 | Np Likeness Score: -2.69 |
References
1. (2012) New compounds, |
2. (2016) Sulfonamide compounds, |